Home News Europe/America News US FDA grants emergency use authorisation to Regeneron Covid-19 antibody given to...

US FDA grants emergency use authorisation to Regeneron Covid-19 antibody given to Trump

1
0
Spread the love
The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, US, September 17, 2020. — Reuters pic
The Regeneron Pharmaceuticals company logo is seen on a building at the company’s Westchester campus in Tarrytown, New York, US, September 17, 2020. — Reuters pic

NOV 21 — The US Food and Drug Administration yesterday issued emergency use authorisation for Regeneron Pharmaceuticals Inc’s Covid-19 antibody therapy, an experimental treatment given to US President Donald Trump that he said helped cure him of the disease.

The FDA said the monoclonal antibodies, casirivimab and imdevimab, should be administered together for the treatment of mild to moderate Covid-19 in adults and paediatric patients with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe Covid-19.

This includes those who are 65 years of age or older or who have certain chronic medical conditions.

The agency said the antibodies are not authorised for patients who are hospitalised due to Covid-19 or require oxygen therapy due to Covid-19. A benefit of casirivimab and imdevimab treatment has not been shown in patients hospitalised due to Covid-19. — Reuters

Cheap Website Traffic

Leave a comment